- Editorial responsibility
- International Journal of Blood Transfusion
Editorial Board
The editors who oversee the assessment of manuscripts for the International Journal of Blood Transfusion, with the affiliation and research interests recorded for each.
Editorial responsibility
Editorial responsibility rests with the Editorial Board. Manuscripts are assessed for scope, scholarly quality, methodological rigor, ethical compliance, and research integrity.
Editorial decisions remain independent of fees, services, memberships and roles. The responsibilities editors work to are set out in the Editors Guidelines.
Members of the Editorial Board
Select a name or photo to open the editor's profile.
-
Catherine Reuben
Muhimbili University of Health and Allied Sciences., Tanzania, United Republic of
Research interests: Health and Allied Sciences
-
Eman NasrEldin
Professor, Assiut University Faculty of Medicine, assiut, assiut, Egypt
Research interests: Transfusion medicine Hematological disease
ORCID 0000-0003-3835-0471
-
Li-Pin Kao
Postdoctoral Research Associate, Center for Cancer Research, Purdue University, U.S.A.
Research interests: Cell Biology · Molecular Biology · Cancer Research
-
MIKAELL FARIA
Faculdade de Medicina de São José do Rio Preto, Brazil
Research interests: Steam Cellrnhsctrn micro biotarncrohnS Diseasernibd
ORCID 0000-0003-4121-0306
-
Nobu Akiyama
Professor, Teikyo University, Tokyo, Japan
Research interests: Hematologic malignancies Acute leukemia Myelodysplastic Syndromes Supportive care for cancer patients Infectious diseases in hematologic diseases Febrile neutropenia Drug-induced hematologic disorders
ORCID 0000-0003-4840-6248
-
PROF OSARO ERHABOR
Department of Haematology, Usmanu Danfodiyo University Sokoto, Nigeria., United Kingdom
Research interests: Blood Transfusion And General Haematology
ORCID 0000-0003-0738-6762
-
Qinqin Xu
LSU health Shreveport, Shreveport, Louisiana., United States
Research interests: My research focused on the molecular mechanism of Immunomodulatory drugs such as lenalidomide and its direct target protein CRBN as well as the CRBN downstream substrates. I am also interested in cancer cell research especially in novel drug exploring for head and neck cancer therapy
-
Saoussen Chouchene
University of Monastir, Tunisia
Research interests: Hematology · Hemostasis · Immunohematology
ORCID 0000-0003-1428-9856
-
Shiwei Duan
Professor, Zhejiang University City College, Hangzhou, Zhejiang, China
Research interests: Epigenomics and pharmacogenomics in anti-cancer chemotherapy (Epi)Genetics and (epi)genomics for cancers and complex diseases
ORCID 0000-0001-7682-2877
-
Venkatesh Ponemone
Executive Director, Clinical Development & Operations TotipotentRX Cell Therapy Pvt. Ltd. Manipal University Gurgaon, Haryana, India.
Research interests: Stem cells transplantation · tissue repair and regeneration · Cord blood haploidentical transplantation
-
Young-Kyun Lee
Seoul National University Bundang Hospital, Seongnam, South Korea
Research interests: Fracture · Osteoporosis · Arthroplasty · Hip · Hip Arthroplasty · Trauma Surgery
ORCID 0000-0001-6564-4294
Guidance for the editorial community
The Editorial Policies set out the journal's ethics and review framework. Reviewer-facing guidance is in the Reviewer Guidelines.
Researchers interested in joining the board may write to info@openaccesspub.org.